Cite
HARVARD Citation
Kang, J. et al. (2018). Heterogeneous responses and resistant mechanisms to crizotinib in ALK‐positive advanced non‐small cell lung cancer. Thoracic cancer. 9 (9), pp. 1093-1103. [Online].
This is an interim version of our Electronic Legal Deposit Catalogue-eJournals and eBooks while we continue to recover from a cyber-attack.
Kang, J. et al. (2018). Heterogeneous responses and resistant mechanisms to crizotinib in ALK‐positive advanced non‐small cell lung cancer. Thoracic cancer. 9 (9), pp. 1093-1103. [Online].